http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040015138-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2002-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2004-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20040015138-A
titleOfInvention Pharmaceutical Combinations Based on Pyridoindolone Derivatives and Anticancer Agents
abstract The present invention relates to a combination of a compound of formula (I) with several anticancer agents.n n n <Formula I>n n n n n n n n R 1 is a hydrogen atom, a methyl group or an ethyl group, and R 2 is a methyl group or an ethyl group; R 1 and R 2 together form a (CH 2 ) 3 group;n n n r 3 is a phenyl group optionally substituted with a halogen atom, a methyl group, a methoxy group or a thienyl group;n n n R 4 is a hydrogen atom, a chlorine atom, a methyl group or a methoxy group.
priorityDate 2001-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415133005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419754775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420094260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414041054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9927196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9901012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426078412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129701966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID234980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413498409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421780937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415892152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9836658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412180311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22277412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420085606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420085608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22277411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57030

Total number of triples: 57.